Post-IPO Equity - Arno Therapeutics
Investment Firm
Overview
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
Announced Date
Aug 16, 2016
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
3
| Investor Name |
|---|
 Arie Belldegrun |
Round Details and Background
Arno Therapeutics raised $8000000 on 2016-08-16 in Post-IPO Equity
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 13, 2016 |  Post-IPO Equity - Arno Therapeutics | 7 | - | 7.4M |
| Aug 16, 2016 | Post-IPO Equity - Arno Therapeutics | 6 | - | 8.0M |
| Oct 30, 2013 | Post-IPO Equity - Arno Therapeutics | 6 | - | 31.0M |
| Sep 14, 2010 | Post-IPO Equity - Arno Therapeutics | 1 | - | 15.0M |
Recent Activity
There is no recent news or activity for this profile.